Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 20;3(1):vdab034. doi: 10.1093/noajnl/vdab034

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — MR1 and CD45 expression does not vary between primary and recurrent glioblastoma. (A) TCGA data show no significant difference between primary and recurrent tumors MR1 mRNA expression levels in GBM. (B) Quantification of MR1 and CD45 IHC staining levels in matched primary and recurrent GBM tissues. (C) IHC of primary and recurrent tumors that were stained for MR1 and CD45 expression. Staining levels for MR1: 0, not detected; +, low (33%); ++, medium (66%); +++, high (˃66%). For CD45 tissue was divided into 4 quadrants: 0 non-detected, +: 1 quadrant positive, ++: 2 quadrants positive, and +++: ˃2 quadrants positive.